Fundraising Fox
Cyrano Therateutics
Delray Beach, US · Founded 2014 · 4 known investors
Find your way into Cyrano Therateutics
Sign up to see every warm intro you have to Cyrano Therateutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyrano Therateutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
Founders & leadership
Cyrano Therateutics was founded in 2014 by Rick Geoffrion.
Board
Investors · 4
How we know: the company's own site · Lumira Ventures's portfolio page · board seat on SEC Form D · funding news · refreshmiami.com · Not right? Tell us
How we know: Remiges Ventures, Inc.'s portfolio page · the company's own site · funding news · refreshmiami.com · Not right? Tell us
Funding
SEC filings, press & company announcements$4.1M disclosed across 1 of 3 rounds · 2020–2025
- Undisclosed amountSeries BMay 2025Source ↗
- Undisclosed amountSeries BJan 2024 · 2 sources
DeepWork Capital (lead), Florida Opportunity Fund (lead), Lumira Ventures, Remiges Ventures
Source ↗
▶$4.1MraisedNov 2020 · 11 investors · Other Health CareRule 506(b)
- Richard GeoffrionExecutive Officer, Director
- Gerry BrunkDirector
- Takahide KodaDirector
- Robert HenkinDirector
- Offering amount
- $12.8M
- Amount sold
- $4.1M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Cyrano Therateutics.
Frequently asked questions
- What does Cyrano Therateutics do?
- Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.
- Who founded Cyrano Therateutics?
- Cyrano Therateutics was founded by Rick Geoffrion in 2014.
- Who are Cyrano Therateutics's investors?
- Cyrano Therateutics's investors include Lumira Ventures, Remiges Ventures, Inc., DeepWork Capital, Florida Opportunity Fund.
- How much funding has Cyrano Therateutics raised?
- Cyrano Therateutics has disclosed $4.1M raised across 1 of its 3 known rounds.
- Where is Cyrano Therateutics headquartered?
- Cyrano Therateutics is headquartered in Delray Beach, US.